Iridex (IRIX) Notes Payables (2011 - 2024)
Iridex's (IRIX) quarterly Notes Payables came in at $1.7 million in Q4 2024, up 31.96% quarter-over-quarter from $1.3 million in Q3 2024.
Iridex (IRIX) Notes Payables (2011 - 2024) Analysis & Trends
Iridex's Notes Payables history runs 9 years deep, the most recent figure standing at $1.7 million for Q4 2024.
- On a quarterly basis, Notes Payables changed N/A year-over-year to $1.7 million in Q4 2024; TTM through Dec 2024 was $1.7 million, a N/A change from a year earlier, with the FY2024 full-year figure at $1.7 million, changed N/A from the prior year.
- Notes Payables rose to $1.7 million in Q4 2024 per IRIX's latest filing, from $1.3 million in the prior quarter.
- Across five years, Notes Payables topped out at $1.7 million in Q4 2024 and bottomed at $15000.0 in Q4 2022.
- The 3-year median for Notes Payables is $403500.0 (2022), against an average of $624125.0.
- Across the five-year window, Notes Payables plunged 97.61% in 2022 and slumped 86.32% in 2023, its largest moves.
- Year by year, Notes Payables stood at $15000.0 in 2022, then surged by 720.0% to $123000.0 in 2023, then soared by 1309.76% to $1.7 million in 2024.
- Per Business Quant, the three latest IRIX Notes Payables figures stand at $1.7 million (Q4 2024), $1.3 million (Q3 2024), and $123000.0 (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Iridex | 15.93 Mn | 11.33 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 28, 2024 | 1.73 Mn |
| Sep 28, 2024 | 1.31 Mn |
| Apr 1, 2023 | 123,000.00 |
| Dec 31, 2022 | 15,000.00 |
| Oct 1, 2022 | 101,000.00 |
| Jul 2, 2022 | 180,000.00 |
| Apr 2, 2022 | 899,000.00 |
| Jan 1, 2022 | 627,000.00 |
| Dec 30, 2017 | 509,000.00 |
| Dec 31, 2016 | 496,000.00 |
| Jan 2, 2016 | 336,000.00 |
| Jan 3, 2015 | 500,000.00 |
| Dec 28, 2013 | 200,000.00 |
| Dec 29, 2012 | 158,000.00 |
| Dec 31, 2011 | 117,000.00 |